We are live on ! Find out more
PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock

Delisted

PHAS was delisted on the 2nd of November, 2022.

Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$3.99M
APM
2
Avidity Partners Management
Texas
$2.64M
RSCM
3
Rock Springs Capital Management
Maryland
$1.67M +$154K +161,044 +6%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.08M -$17.3K -18,033 -1%
MCM
5
MAI Capital Management
Ohio
$1.02M +$278K +290,825 +21%
JJ
6
Johnson & Johnson
New Jersey
$964K
CA
7
CHI Advisors
New York
$450K +$718K +750,000 New
BlackRock
8
BlackRock
New York
$411K +$2.6K +2,713 +0.4%
Stifel Financial
9
Stifel Financial
Missouri
$264K +$141K +147,267 +50%
DCM
10
DAFNA Capital Management
California
$227K
Geode Capital Management
11
Geode Capital Management
Massachusetts
$192K
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$164K -$50.3K -52,490 -16%
PTP
13
Platform Technology Partners
New York
$146K +$409 +427 +0.2%
NLG
14
New Legacy Group
New York
$144K
BCM
15
Bridgeway Capital Management
Texas
$76K -$153K -160,000 -56%
Marshall Wace
16
Marshall Wace
United Kingdom
$73K -$94.3K -98,444 -44%
Jane Street
17
Jane Street
New York
$68K +$108K +112,668 New
Citadel Advisors
18
Citadel Advisors
Florida
$65K +$103K +107,953 New
Morgan Stanley
19
Morgan Stanley
New York
$64K -$32.6K -34,102 -24%
State Street
20
State Street
Massachusetts
$55K +$3.83K +4,000 +5%
SCA
21
Snowden Capital Advisors
New York
$36K +$8.62K +9,000 +17%
Northern Trust
22
Northern Trust
Illinois
$35K
Prudential Financial
23
Prudential Financial
New Jersey
$26K +$42.2K +44,100 New
NFC
24
Northeast Financial Consultants
Connecticut
$23K
William Blair & Company
25
William Blair & Company
Illinois
$21K